ACOR
Price:
$0.661
Market Cap:
$821.03K
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the manage...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-02-10
Stock Exchange
NASDAQ
Ticker
ACOR
According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 786.07%. This represents a change of 2.44% compared to the average of 30.93% of the last 4 quarters.
The mean historical ROE of Acorda Therapeutics, Inc. over the last ten years is -14.64%. The current 786.07% ROE has changed -5468.53% with respect to the historical average. Over the past ten years (40 quarters), ACOR's ROE was at its highest in in the December 2023 quarter at 137.86%. The ROE was at its lowest in in the September 2019 quarter at -93.67%.
Average
-14.64%
Median
-23.57%
Minimum
-87.82%
Maximum
160.08%
Discovering the peaks and valleys of Acorda Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 711.88%
Maximum Annual ROE = 160.08%
Minimum Annual Increase = -1695.66%
Minimum Annual ROE = -87.82%
| Year | ROE | Change |
|---|---|---|
| 2023 | 160.08% | -327.36% |
| 2022 | -70.41% | 2.36% |
| 2021 | -68.78% | 64.34% |
| 2020 | -41.85% | -52.34% |
| 2019 | -87.82% | -1695.66% |
| 2018 | 5.50% | -112.81% |
| 2017 | -42.95% | 711.88% |
| 2016 | -5.29% | -388.52% |
| 2015 | 1.83% | -43.94% |
| 2014 | 3.27% | -12.39% |
The current ROE of Acorda Therapeutics, Inc. (ACOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.96%
5-year avg
-21.76%
10-year avg
-14.64%
Acorda Therapeutics, Inc.’s ROE is greater than Neptune Wellness Solutions Inc. (-88.52%), greater than RxElite, Inc. (-273.67%), less than Green Hygienics Holdings Inc. (148.83%), greater than Mallinckrodt plc (-26.10%), greater than Hempacco Co., Inc. (-360.22%), less than PotNetwork Holdings, Inc. (258.08%), less than High Fusion Inc. (324.02%), less than RCMW Group, Inc. (0%), less than Lucy Scientific Discovery Inc. (18.15%), less than NewBridge Global Ventures, Inc. (0%),
| Company | ROE | Market cap |
|---|---|---|
| -88.52% | $453.00 | |
| -273.67% | $1.48K | |
| 148.83% | $44.00 | |
| -26.10% | $0 | |
| -360.22% | $592.00 | |
| 258.08% | $91.00K | |
| 324.02% | $767.56K | |
| 0% | $2.03M | |
| 18.15% | $906.91K | |
| 0% | $769.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Acorda Therapeutics, Inc.'s ROE?
How is the ROE calculated for Acorda Therapeutics, Inc. (ACOR)?
What is the highest ROE for Acorda Therapeutics, Inc. (ACOR)?
What is the 3-year average ROE for Acorda Therapeutics, Inc. (ACOR)?
What is the 5-year average ROE for Acorda Therapeutics, Inc. (ACOR)?
How does the current ROE for Acorda Therapeutics, Inc. (ACOR) compare to its historical average?